[ad_1] Shilpa Medicare Ltd shares rose over 6% in early trade on Tuesday, November 19, after its subsidiary secured a Certificate of Suitability (CEP) from a European drug regulator for an API used in hypertension treatment. Shilpa Pharma Lifesciences, the company’s subsidiary, received the CEP from the European Directorate for the Quality of Medicines & […]
Headline
Tag: Shilpa Medicare EDQM approval
Back To Top